Masimo Corporation MASI
Jun 12, 2026, 9:30 AM EDT
52-week range unavailable
- YTD
- +38.36%
- 1 year
- +8.84%
- Market cap
- 9.42B
- Profit margin
- 4.90%
- YTD return
- +38.36%
- 1-year return
- +8.84%
- Open
- 179.95
- Previous close
- 179.95
- Day's range
- 179.95 – 179.95
- Earnings date
- Aug 4, 2026
Key statistics
- Enterprise value
- 9.79B
- PEG ratio
- 0.49
- Price / sales
- 0.00
- Price / book
- 11.91
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Total cash
- 0
- Total debt
- 9
- Return on equity
- 9.08%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
- Strong buy0
- Buy0
- Hold5
- Sell0
- Strong sell0
Next earnings
Aug 4, 2026
Expected Aug 4, 2026. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 4, 2026 | Jun 30, 2026 | 1.43 | — | — | — |
| May 5, 2026 | Apr 4, 2026 | 1.41 | 1.43 | +0.02 | +1.42% |
| Feb 26, 2026 | Jan 3, 2026 | 1.48 | 0.18 | -1.30 | -87.84% |
| Nov 4, 2025 | Sep 27, 2025 | 1.19 | 1.32 | +0.13 | +10.92% |
| Aug 5, 2025 | Jun 28, 2025 | 1.23 | 1.33 | +0.10 | +8.13% |
| May 6, 2025 | Mar 29, 2025 | 1.24 | 1.36 | +0.12 | +9.68% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 27, 2026 | Raymond James | down | Outperform | Market Perform |
| Feb 18, 2026 | Wells Fargo | down | Overweight | Equal-Weight |
| Feb 18, 2026 | BTIG | down | Buy | Neutral |
| Dec 4, 2025 | BTIG | main | Buy | Buy |
| Nov 24, 2025 | BTIG | reit | Buy | Buy |
| Nov 17, 2025 | B of A Securities | init | — | Neutral |
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- Employees
- 7,500
- Website
- masimo.com
News
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover 
Sirius XM Holdings Will Replace Masimo Corp. In The S&P MidCap 400 Effective Prior To The Opening Of Trading On Thursday, June 11 
Masimo Stockholders Approve Merger Agreement With Danaher, Mobius Merger Sub 
Earnings Scheduled For February 26, 2026 
Danaher's Masimo Acquisition: Solid Financials, Conservative Growth Projections 
This Masimo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday 
Top 3 Health Care Stocks That May Collapse This Quarter 
Software Stocks Drop, Silver Plunges 6% To $72: What's Moving Markets Tuesday? 
12 Health Care Stocks Moving In Tuesday's Intraday Session 
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday
Your note
Sign in to keep a note on MASI — it syncs with the Stock Master app.